Cipla Ltd.: Clinical Trials

10 trials sponsored by Cipla Ltd., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 recruiting, 1 suspended. 6 Phase 3, 2 Phase 2, 1 Not applicable, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 22Completed 1, Suspended 1
Not applicable1Completed 1
Phase 41Completed 1

Follow Cipla Ltd.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
Pramipexole ER, Escitalopram - Major Depressive Disorder, Mild Neurocognitive Disorder
Phase 2SuspendedNational Institute of Allergy and Infectious Diseases (NIAID)1862026-05-172026-07-14
A Study of LY900014 in Adult Participants With Type 2 Diabetes Mellitus in India
Insulin Lispro-aabc, Insulin Glargine - Diabetes Mellitus, Type 2
Phase 4CompletedEli Lilly and Company1532024-04-182026-09-28
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation), Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1, Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2 - Bronchial Asthma
Phase 3CompletedCipla Ltd.1202023-12-062025-07-16
BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient
Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation Aerosol, Placebo - Asthma
Phase 3CompletedCipla Ltd.14852022-04-152023-08-30
BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
Fluticasone propionate/salmeterol 100/50 µg, Placebo, Advair Diskus 100/50 Dry Powder Inhaler, 60 ACTUAT - Bronchial Asthma
Phase 3CompletedCipla Ltd.13662018-10-172020-08-13
Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden
SPIRIT Intervention - Tuberculosis, HIV/AIDS
Not applicableCompletedUniversity of California, San Francisco1632017-11-152025-06-18
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
90 mcg Reference Product, 180 mcg Reference Product, 90 mcg Test Product - Bronchial Asthma
Phase 3CompletedCipla Ltd.1102015-12-012019-07-25
Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis
Prednisolone, Voriconazole - Allergic Bronchopulmonary Aspergillosis
Phase 2 / Phase 3CompletedPost Graduate Institute of Medical Education and Research, Chandigarh502013-06-012017-12-12
Prevention of Postpartum Haemorrhage With Sublingual Misoprostol or Oxytocin
Misoprostol, Oxytocin - Postpartum Hemorrhage
Phase 3CompletedJawaharlal Nehru Medical College6522007-03-012011-06-14
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
HIV Infections, Hepatitis B
RecruitingSyneos Health242581989-01-012025-04-01

Conditions studied

Asthma (4)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Aspergillosis, Allergic Bronchopulmonary (1)  ·  Depressive Disorder, Major (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  HIV Infections (1)  ·  Hepatitis (1)  ·  Hepatitis B (1)  ·  Neurocognitive Disorders (1)  ·  Postpartum Hemorrhage (1)  ·  Tuberculosis (1)

Interventions

Albuterol (2)  ·  Budesonide (1)  ·  Budesonide, Formoterol Fumarate Drug Combination (1)  ·  Escitalopram (1)  ·  Fluticasone (1)  ·  Insulin Glargine (1)  ·  Misoprostol (1)  ·  Oxytocin (1)  ·  Prednisolone (1)  ·  Salmeterol Xinafoate (1)  ·  Voriconazole (1)

Countries

United States (6)  ·  India (4)  ·  Uganda (2)  ·  Botswana (1)  ·  Brazil (1)  ·  Kenya (1)  ·  Malawi (1)  ·  Mexico (1)  ·  Peru (1)  ·  Philippines (1)  ·  South Africa (1)  ·  Thailand (1)  ·  Vietnam (1)  ·  Zimbabwe (1)

Top investigators

Dhiraj Abhyankar (1)  ·  Diane Havlir, MD (1)  ·  Gabriel Chamie, MD, MPH (1)  ·  Jessica D Albano, PhD, MPH (1)  ·  M B Bellad, M.D. (1)  ·  Orlando Rivero, MD (1)  ·  Sarah Smiley (1)  ·  Scott Letendre, MD (1)  ·  William R Short, MD (1)

Results publications

PMID 26269220, PMID 26687320, PMID 30049743, PMID 35908553, PMID 38454501, PMID 39552330, PMID 40313133, PMID 40766233

NIH funding

R01AI125000 (1)